<DOC>
	<DOCNO>NCT00201253</DOCNO>
	<brief_summary>The purpose study ass lung immune response patient active pulmonary tuberculosis ( TB ) healthy control person expose Mycobacterium tuberculosis household patient TB unexposed .</brief_summary>
	<brief_title>Expression Tuberculosis Lung</brief_title>
	<detailed_description>BACKGROUND : M. tuberculosis infects third world 's population , TB lead cause morbidity mortality due single infectious agent . However , 5 % 10 % M. tuberculosis-infected subject without underlie immunodeficiency develop disease lifetime . Therefore protective immunity induce majority subject . Understanding correlate protection M. tuberculosis human need well direct effort development antituberculosis vaccine . DESIGN NARRATIVE : Patients treat accord good clinical practice ; however , study medication give part research study . This study involve one-time bronchoalveolar lavage venipuncture obtain immune cell laboratory study immune response .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<criteria>TB patient 18 65 year old Clinical radiographic sign symptoms consistent pulmonary TB Start date antituberculous chemotherapy le 10 day prior procedure Sputum smear positive acid fast bacilli Drugsensitive , cultureconfirmed growth M. tuberculosis sputum Willing provide inform consent participation bronchoalveolar lavage venipuncture study TB patient HIV1 coinfection History chronic medical condition require daily medication ( include diabetes mellitus , hypertension , chronic infection , renal cardiac failure , peptic ulcer disease ) History asthma upper low respiratory tract infection within 2 month study Hemoglobin level less 10g/dl</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>